|1||NCT02380521||Completed||Exenatide Once Weekly, Cardiovascular Risk and Type-2 Diabetes||
||Other / Industry||
||60||All||18 Years to 80 Years (Adult, Senior)||NCT02380521||ESR-14-10139||January 2015||July 2016||November 2016||March 5, 2015||November 8, 2016||
|Effects of Exenatide Long-Acting Release on Glucose Control and Safety in Subjects With Type 2 Diabetes Mellitus(DURATION - 1)||
||303||All||16 Years and older (Child, Adult, Senior)||NCT00308139||2993LAR-105 (DURATION - 1)
|April 2006||July 2008||August 2014||March 29, 2006||August 26, 2015||August 17, 2012||
† Study has passed its completion date and status has not been verified in more than two years.